Study: FDA allowed mail-order abortion pills without ‘sufficient evidence’ of safety

A study by scholars at the pro-life Charlotte Lozier Institute found that the U.S. Food and Drug Administration (FDA) “lacked sufficient evidence” to remove the in-person abortion pill dispensing rule.

Published in Issues in Law and Medicine, a journal of the Alliance for Hippocratic Medicine, on Oct. 6, the report found that the FDA’s studies on the abortion pill didn’t reflect real-world conditions of abortion pill use.

According to the article, the FDA relied on analysis from groups with political incentives. Additionally, the FDA used “inadequate” adverse event reporting, authors Zachery Sluzala and Ingrid Skop found.

“When federal agencies remove regulations designed to safeguard patient health, those decisions should be grounded in evidence that reflects real-world practice,” Skop, an OB-GYN who works for the Lozier Institute, said in a statement .

“Our analysis found that the FDA’s review fell well short of that standard. Safety decisions should reflect the conditions in which women are using the drugs, not tightly controlled study conditions that fail to mimic real-world use.”

Pro-life groups criticize FDA abortion pill update In a court-ordered update of the…